Press releases
- Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
- Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
- Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
Key statistics
On Tuesday, Omeros Corp (3O8:DUS) closed at 3.39, 240.67% above the 52 week low of 0.9945 set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.36 |
---|---|
High | 3.41 |
Low | 3.36 |
Bid | 3.35 |
Offer | 3.43 |
Previous close | 3.39 |
Average volume | 12.00 |
---|---|
Shares outstanding | 57.94m |
Free float | 55.40m |
P/E (TTM) | -- |
Market cap | 212.66m USD |
EPS (TTM) | -2.79 USD |
Data delayed at least 15 minutes, as of May 07 2024 18:30 BST.
More ▼